Skip to main content
. 2018 Jan 4;19(1):102. doi: 10.3390/ijms19010102

Figure 2.

Figure 2

Putative targets for ALA in transplantation. ROS could be produced by the donor, the ischemic organ and the recipient during reperfusion. ALA could be administered to the donor and recipient, or could be used to perfuse the organ during cold ischemia time. (ROS, Reactive oxygen species; BMI, Body mass index; ALA, Alpha lipoic acid).